Business · 14/07/1994Updated: 10/16/2026 · 1 min read

National Cancer Institute: Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Biomedical Use of Novel Approaches for Lentivirus Vaccine Development

The National Cancer Institute seeks a CRADA with a pharmaceutical or biotechnology company to develop a novel Lentivirus vaccine using site-directed mutagenesis and immunodominant decoy epitopes.